Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
United States
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Dispatch Clinical
Dispatch Biotherapeutics